Genmab (CPSE:GMAB) Valuation in Focus After Recent Share Price Pullback [Yahoo! Finance]
Genmab A/S - American Depositary Shares (GMAB)
Company Research
Source: Yahoo! Finance
Over the past month, shares have pulled back. This development has raised new questions about the outlook for this biotechnology company. See our latest analysis for Genmab. Genmab's share price may have dipped 8.5% over the last month, but momentum remains robust with a 25.2% gain year-to-date. The 12-month total shareholder return of 32.5% suggests that, despite recent volatility, investors have enjoyed solid long-term rewards as interest in biotech and healthcare innovation continues to shape market sentiment. If you're interested in spotting the next breakthrough, now is a great time to explore the opportunities waiting in our See the full list for free. With shares now trading about 7% below analyst targets but up significantly year-to-date, investors are left to consider whether recent weakness signals an undervalued entry point, or if strong expectations for Genmab are already fully reflected in the price. Most Popular Narrative: 6.9% Undervalued Genmab's most widel
Show less
Read more
Impact Snapshot
Event Time:
GMAB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GMAB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GMAB alerts
High impacting Genmab A/S - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
GMAB
News
- Assessing Genmab (CPSE:GMAB) Valuation After Its Recent Share Price Strength [Yahoo! Finance]Yahoo! Finance
- Genmab (GMAB) Q3 2025 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Bicara Therapeutics: Intriguing Opportunity Given Rival Merus' $8B Buyout [Seeking Alpha]Seeking Alpha
- Grant of Restricted Stock Units and Warrants to Employees in Genmab [Yahoo! Finance]Yahoo! Finance
- Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated personsGlobeNewswire